A third of community-dwelling elderly with intermediate and high level of Alzheimer's neuropathologic changes are not demented: A meta-analysis
- PMID: 31899366
- DOI: 10.1016/j.arr.2019.101002
A third of community-dwelling elderly with intermediate and high level of Alzheimer's neuropathologic changes are not demented: A meta-analysis
Abstract
This systematic review and meta-analysis assessed the bidirectional association between AD pathology and dementia in community-dwelling elderly populations. We searched PubMed/MEDLINE, Embase, Scopus, Web of Science, and references of the pertinent articles for community/population-based longitudinal cohorts with regular assessment of cognitive status of participants followed by postmortem neuropathology data, with no language and date restrictions, until 20 September 2019. Finally, we retrieved 18 articles with data from 17 cohorts comprising 4677 persons. Dementia was twice as likely in participants with definitive neuropathological indicator for AD compared to those without it: moderate/high Braak and Braak (BB) stages III-VI of neurofibrillary tangles (54 % vs. 26 % in participants with BB stages 0-II), the Consortium to Establish a Registry for AD (CERAD) moderate/frequent neuritic plaques scores (64 % vs. 33 % in participants with CERAD none/infrequent), and National Institute on Aging and the Reagan Institute of the Alzheimer's Association criteria intermediate/high AD probability (52 % vs. 28 % in participants with no/low AD probability). Accordingly, a substantial proportion of community-dwelling elderly people with definitive AD pathology may not develop dementia. Brain reserve or contribution of other factors and pathologies, such as vascular and degenerative pathology to dementia might explain this apparent discrepancy. These findings also suggest caution in equating Alzheimer pathology biomarkers with dementia.
Keywords: Alzheimer disease; Autopsy; Community health planning; Dementia; Neuropathology.
Copyright © 2019 Elsevier B.V. All rights reserved.
Similar articles
-
Characterizing Apolipoprotein E ε4 Carriers and Noncarriers With the Clinical Diagnosis of Mild to Moderate Alzheimer Dementia and Minimal β-Amyloid Peptide Plaques.JAMA Neurol. 2015 Oct;72(10):1124-31. doi: 10.1001/jamaneurol.2015.1721. JAMA Neurol. 2015. PMID: 26302353 Free PMC article.
-
Cerebral Amyloid Angiopathy, Dementia, and Alzheimer Neuropathologic Changes: Findings From the ACT Autopsy Cohort.Neurology. 2024 Nov 26;103(10):e210009. doi: 10.1212/WNL.0000000000210009. Epub 2024 Oct 31. Neurology. 2024. PMID: 39481068
-
Cancer diagnosis is associated with a lower burden of dementia and less Alzheimer's-type neuropathology.Brain. 2022 Jul 29;145(7):2518-2527. doi: 10.1093/brain/awac035. Brain. 2022. PMID: 35094057 Free PMC article.
-
Neuropathology of Alzheimer's disease: a critical update.J Neural Transm Suppl. 1998;54:77-95. doi: 10.1007/978-3-7091-7508-8_8. J Neural Transm Suppl. 1998. PMID: 9850917 Review.
-
The neuropathological diagnosis of Alzheimer disease.J Neural Transm Suppl. 1998;53:97-118. doi: 10.1007/978-3-7091-6467-9_9. J Neural Transm Suppl. 1998. PMID: 9700649 Review.
Cited by
-
Resistance and resilience to tau pathology in Alzheimer's disease: Effects of age, sex, and APOE alleles.Alzheimers Dement (Amst). 2024 Oct 12;16(4):e70016. doi: 10.1002/dad2.70016. eCollection 2024 Oct-Dec. Alzheimers Dement (Amst). 2024. PMID: 39398945 Free PMC article.
-
Midlife occupational cognitive requirements protect cognitive function in old age by increasing cognitive reserve.Front Psychol. 2022 Dec 8;13:957308. doi: 10.3389/fpsyg.2022.957308. eCollection 2022. Front Psychol. 2022. PMID: 36571008 Free PMC article.
-
Measurement of carotid plaque burden: A tool for predicting and preventing dementia?Cereb Circ Cogn Behav. 2021 Jan 30;2:100004. doi: 10.1016/j.cccb.2021.100004. eCollection 2021. Cereb Circ Cogn Behav. 2021. PMID: 36324719 Free PMC article.
-
Biological aging processes underlying cognitive decline and neurodegenerative disease.J Clin Invest. 2022 May 16;132(10):e158453. doi: 10.1172/JCI158453. J Clin Invest. 2022. PMID: 35575089 Free PMC article. Review.
-
Prevention and Treatment Strategies for Alzheimer's Disease: Focusing on Microglia and Astrocytes in Neuroinflammation.J Inflamm Res. 2024 Oct 13;17:7235-7259. doi: 10.2147/JIR.S483412. eCollection 2024. J Inflamm Res. 2024. PMID: 39421566 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical